Overcoming acquired treatment resistance is one of the major challenges in the fight against cancer. While combination therapies hold promise, their toxicity to healthy tissue remains a major hurdle.

This article was originally republished from The Conversation. Bringing a new drug to market costs billions of dollars and can take over a decade. These high monetary and time investments are both ...

A frequently reported fact in the drug discovery and development industry is that approximately 90 % of drug candidates reaching clinical trials fail, with even higher amounts discarded before ...